Monday Feb 10, 2014
Conrad
Duke of Windsor
Park South
East Foyer
th
3 Floor Networking Breakfast: Grand Ballroom
8:00 – 8:45am
Fireside Chat: Richard F. Pops, Chairman & CEO, Alkermes plc (Astor)
9:00 – 9:25am
Galena Biopharma
Celator Pharmaceuticals
9:30 – 9:55am
Agenus
NovaBay Pharmaceuticals
10:00 – 10:25am
CytoDyn
Synthetic Biologics
10:30 – 10:55am
PAION AG
Prima BioMed
11:00 – 11:25am
Innovus Pharmaceuticals
Cyclacel Pharmaceuticals
Opexa Therapeutics
Immune Pharmaceuticals
12:00 – 12:55pm
Affimed Kids V Cancer (PAG) Proteon Therapeutics
Covagen Sutro Biopharma Mirna Therapeutics Cerecor KemPharm Epilepsy Foundation (PAG) ALS TDI (PAG) Targazyme Apogenix
Intrexon Corporation
Auxilium Pharmaceuticals
Relypsa
Prosensa
Regado Biosciences
ZIOPHARM Oncology
OncoMed Pharmaceuticals
Lexicon Pharmaceuticals
Onconova Therapeutics
Synergy Pharmaceuticals
Northwest Biotherapeutics
Karo Bio AB
Melanoma Research Alliance (PAG) Immune Design
Anavex Life Sciences Corp.
NeoStem
1:30 – 1:55pm
GenSpera
Resverlogix
2:00 – 2:25pm
Newron Pharmaceuticals S.p.A.
Anthera Pharmaceuticals
DARA BioSciences
2:30 – 2:55pm
StemCells
CytRx Corporation
Rexahn Pharmaceuticals
BioLineRx
Stallergenes
3:00 – 3:25pm
Soligenix
TG Therapeutics
Stem Cell Therapeutics
Biotie Therapies
Progenics Pharmaceuticals
3:30 – 3:55pm
Immunovaccine
GTx
Alcobra
Repros Therapeutics
4:00 – 4:25pm
Celsus Therapeutics
Galectin Therapeutics
OncoSec Medical
Keryx Biopharmaceuticals
Chimerix
Bavarian Nordic A/S
5:00 – 7:00pm Waldorf Astoria Hotel New York, NY
1x1 (1 & 2) Business Roundtable: Solution Development: Aiming the Whole Pipeline at a Single Goal (Jade)
1x1 (3) 1x1 (4) 1x1 (5)
Therapeutic Workshop: Delivering the (RNAi) Goods (Jade)
1x1 (6) 1x1 (7) 1x1 (8)
Opening Remarks & Opening Plenary Session - A Room with a (Buy-Side) View: The Year Ahead (Astor) – Box Lunch
1:00 – 1:25pm
4:30 – 4:55pm
1x1 Timeslots th 8 Floor
Jade/Astor
rd
4 Floor
7:00 – 7:55am
11:30 – 11:55am
Basildon
La Jolla Pharmaceutical Sorrento Therapeutics Company
Probiodrug AG Nuron Biotech
Amarantus BioScience Tonix Pharmaceuticals Intra-Cellular Therapies
Conatus Pharmaceuticals ImmunoCellular Therapeutics Five Prime Therapeutics
Mesoblast
1x1 (11)
Navidea Biopharmaceuticals
1x1 (12)
Rigel Pharmaceuticals
Welcome Reception (Empire Room) As of 2/9/2014: Schedule subject to change. -1-
Therapeutic Workshop: Balancing the Risk-Reward in Rare Disease Drug Development (Jade)
1x1 (13) 1x1 (14) 1x1 (15)
Fireside Chat: Christopher A. Viehbacher CEO, Sanofi – (Astor)
Legend Blue: Private Company PAG: Patient Advocacy Group
1x1 (16) 1x1 (17) 1x1 (18)
www.bio.org/bioceo
[email protected]
7:00 – 7:55am
Networking Breakfast: Grand Ballroom
1x1s th 8 Floor 1x1 (19)
8:00 – 8:45am
Fireside Chat: David E.I. Pyott, CEO and Chairman of the Board, Allergan (Astor)
1x1 (20)
Tuesday Feb 11, 2014
Conrad
Duke of Windsor th 4 Floor
8:30 – 8:55am
Tekmira Pharmaceuticals
Trovagene
9:00 – 9:25am
Benitec Biopharma
Retrophin
9:30 – 9:55am
Apricus Biosciences
Columbia Laboratories
10:00 – 10:25am
Cytokinetics
SYGNIS AG
10:30 – 10:55am
Novelos Therapeutics
Aradigm Corporation
11:00 – 11:25am
TiGenix N.V.
OXiGENE
11:30 – 11:55am
RXi Pharmaceuticals
Cleveland BioLabs
Park South
Opsona Therapeutics Nora Therapeutics BeiGene Isarna Therapeutics Aduro BioTech Kadmon Corporation Melinta Therapeutics TxCell SA CymaBay Therapeutics MaxCyte
Basildon
East Foyer rd 3 Floor
KaloBios Pharmaceuticals
Exelixis
Ohr Pharmaceutical
AcelRx Pharmaceuticals
pSiVida
Arena Pharmaceuticals
SciClone Pharmaceuticals
Gilead Sciences
1x1 (24)
Inovio Pharmaceuticals
OvaScience
1x1 (25)
Heat Biologics
ProMetic Life Sciences
Stemline Therapeutics
Regulus Therapeutics
Trevena
12:00 – 12:55pm (Box Lunch) 1:00 – 1:25pm 1:30 – 1:55pm
Immunocore Pieris AG XDx
Business Roundtable: The Reimbursement Landscape Under ACA (Jade) Catalyst Pharmaceutical Partners Actinium Pharmaceuticals
Jade/Astor
1x1 (21) Business Roundtable: Let’s Make a Deal: Strategic Licensing & M&A Trends (Jade)
Fireside Chat: Leonard Bell, MD, Chief Executive Officer, Alexion (Astor)
Fireside Chat: 12:00 – 12:45pm Belén Garijo, MD, President and CEO, Merck Serono (Astor)
ReNeuron Group plc
Codexis
BIND Therapeutics
Cempra
Advanced Cell Technology
MetaStat
GlycoMimetics
Alnylam Pharmaceuticals
1x1 (22) 1x1 (23)
1x1 (26) 1x1 (27) 1x1 (28/29) 1x1 (30)
Therapeutic Workshop: Keeping an I on Oncology: The ASCO Immunotherapy Preview (Jade)
1x1 (31)
2:00 – 2:25pm
GENFIT
Athersys
Ignyta
Horizon Pharma
Cancer Genetics
2:30 – 2:55pm
AntriaBio
Targacept
Selvita S.A.
Idera Pharmaceuticals
Orexigen Therapeutics
1x1 (33)
3:00 – 3:25pm
DiaMedica
Neuralstem
CEL-SCI Corporation
Tetraphase Pharmaceuticals
Verastem
1x1 (34)
3:30 – 3:55pm
Biodel
Transition Therapeutics
Advaxis
Epizyme
PDL BioPharma
1x1 (35)
4:00 – 4:55pm
Closing Plenary Session: Fundraising in the New Capital Market Environment (Astor)
5:00 – 6:00pm
Closing Happy Hour (Jade)
Waldorf Astoria Hotel New York, NY
As of 2/9/2014: Schedule subject to change. -2-
1x1 (32)
Legend Blue: Private Company PAG: Patient Advocacy Group www.bio.org/bioceo
[email protected]
